We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.86B
AUM Growth
+$362M
Cap. Flow
+$499M
Cap. Flow %
10.26%
Top 10 Hldgs %
17.76%
Holding
548
New
154
Increased
98
Reduced
117
Closed
170

Sector Composition

Rank Sector Weight
1 Healthcare 12.84%
2 Financials 10.91%
3 Industrials 10.79%
4 Energy 9.19%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAS
251
DELISTED
RAIT Financial Trust
RAS
$3.64M 0.07%
489,911
+55,155
+13% +$435K
TIF
252
DELISTED
Tiffany & Co.
TIF
$3.61M 0.07%
+37,500
New +$3.74M
AAPL icon
253
Apple
AAPL
$4.57T
$3.6M 0.07%
+143,080
New +$3.51M
AVNR
254
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$3.58M 0.07%
300,000
+21,682
+8% +$148K
BGC
255
DELISTED
General Cable Corporation
BGC
$3.49M 0.07%
+231,497
New +$5.07M
TUBE
256
DELISTED
TubeMogul, Inc.
TUBE
$3.45M 0.07%
+300,000
New +$3.25M
WINT
257
DELISTED
Windtree Therapeutics Inc
WINT
$3.44M 0.07%
133,462
-6,312
-5% -$152K
MKTO
258
DELISTED
MARKETO INC COM STK (DE)
MKTO
$3.44M 0.07%
106,374
-334,502
-76% -$9.76M
QTNT
259
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
$3.28M 0.07%
8,706
-89
-1% -$32.5K
GNMK
260
DELISTED
GenMark Diagnostics, Inc
GNMK
$3.26M 0.07%
363,695
-17,201
-5% -$185K
XENT
261
DELISTED
Intersect ENT, Inc
XENT
$3.21M 0.07%
+207,123
New +$3.12M
BLUE
262
DELISTED
bluebird bio
BLUE
$3.15M 0.06%
+6,767
New +$3.12M
SAGE
263
DELISTED
Sage Therapeutics
SAGE
$3.14M 0.06%
+99,674
New +$2.89M
BKU icon
264
Bankunited
BKU
$3.36B
$3.14M 0.06%
102,923
-547,077
-84% -$17.4M
AIG icon
265
CALL
American International
AIG
$41.3B
$3M 0.06%
55,600
TBCH
266
Turtle Beach Corp
TBCH
$277M
$2.93M 0.06%
95,611
-4,522
-5% -$140K
PRKS icon
267
United Parks & Resorts
PRKS
$2.12B
$2.85M 0.06%
148,477
-201,520
-58% -$4.81M
HQY icon
268
HealthEquity
HQY
$8.75B
$2.82M 0.06%
+154,047
New +$2.96M
AA icon
269
Alcoa
AA
$13.2B
$2.69M 0.06%
+69,684
New +$2.73M
LMNS
270
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$2.58M 0.05%
290,165
-13,724
-5% -$126K
JBL icon
271
Jabil
JBL
$35.8B
$2.52M 0.05%
+124,937
New +$2.61M
VTTI
272
DELISTED
VTTI Energy Partners LP
VTTI
$2.51M 0.05%
+100,320
New +$2.47M
AXAS
273
DELISTED
Abraxas Petroleum Corp
AXAS
$2.51M 0.05%
23,797
+4,047
+20% +$452K
LRMR icon
274
Larimar Therapeutics
LRMR
$432M
$2.5M 0.05%
10,579
-5,195
-33% -$1.18M
WD icon
275
Walker & Dunlop
WD
$1.53B
$2.49M 0.05%
187,421
-8,866
-5% -$123K

Similar funds

Alyeska Investment Group's Q3 2014 Portfolio in Review

As of Q3 2014, Alyeska Investment Group held 548 positions worth $4.86B, up 8% from $4.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $499M of net new capital in Q3 2014, opening 154 new positions and adding to 98 existing holdings. Its largest new stake was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Vistance Networks Inc, an estimated $35.4M trimmed.

  • Alyeska Investment Group's largest Q3 2014 buy was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.
  • Alyeska Investment Group added most to DIRECTV COM STK (DE) in Q3 2014, an estimated $38.9M increase.
  • Alyeska Investment Group's biggest Q3 2014 reduction was Vistance Networks Inc, cutting an estimated $35.4M.
  • Alyeska Investment Group fully exited Amsurg Corp in Q3 2014, selling an estimated $72.9M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.86B portfolio in Q3 2014.
  • Alyeska Investment Group opened 154 new positions and closed 170 in Q3 2014.
  • Alyeska Investment Group's portfolio value rose 8% quarter-over-quarter to $4.86B.

Based on Alyeska Investment Group's 13F filing for Q3 2014, filed 14 Nov 2014.